Regarding the goal of data and safety monitoring which of the following is INCORRECT:
A. Ensure that risks of participation in a clinical study are minimized as far as is reasonably possible.
B. Ensure the integrity of the data collected in a clinical study.
C. Halt a study if safety concerns arise.
D. Ensure that efficacy endpoints are met.
E. Preparation of periodic data summary reports to determine if the study should change in any way or be halted.